Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells and Schwann cells
- PMID: 21034560
Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells and Schwann cells
Abstract
Background: The most important objective of transplant studies in the injured spinal cord has been to provide a favorable environment for axonal growth. Moreover, the continuing discovery of new grafts is providing new potentially interesting transplant candidates. Our purpose was to observe the morphological and functional repair effects of the co-transplantation of neural stem cell (NSC), Schwann cells (SCs) and poly lactide-co-glycolide acid (PLGA) on the spinal cord injury of rats.
Methods: A scaffold of PLGA was fabricated. NSCs and SCs were cultured, with the NSCs labeled with 5-bromodeoxyuridine, and the complex of NSC/PLGA or NSC + SCs/PLGA were constructed. Thirty-six Wistar rats were randomly divided into three groups: group A (transplantation of PLGA), group B (transplantation of NSC/PLGA) and group C (transplantation of NSC + SCs/PLGA). The 3 mm length of the right hemicord was removed under the microscope in all rats. The PLGA or the complex of PLGA-cells were implanted into the injury site. Basso-Beattie-Bresnahan (BBB) locomotion scores, motor and somatosensory evoked potential of lower limbs were examined to learn the rehabilitation of sensory and motor function at 4 weeks, 8 weeks, 12 weeks and 24 weeks after injury. All the recovered spinal cord injury (SCI) tissues were observed with HE staining, immunohistochemistry, and transelectronmicroscopy to identify the survival, migration and differentiation of the transplanted cells and the regeneration of neural fibres at 4 weeks, 8 weeks, 12 weeks and 24 weeks after injury.
Results: (1) From 4 weeks to 24 weeks after injury, the BBB locomotion scores of cell-transplanted groups were better than those of the non-cell-transplanted group, especially group C (P < 0.05). The amplitudes of the somatosensory evoked potential (SEP) and motor-evoked potential (MEP) were improved after injury in groups B and C, but the amplitude of SEP and MEP at 4 weeks was lower than that at 12 weeks and 24 weeks after injury. Compared with group B, the amplitude of SEP and MEP in group C was improved. The amplitude of SEP and MEP was not improved after injury in group A. (2) HE staining revealed the volume of the scaffold decreased and the number of cells in the scaffold increased. Newly-grown capillaries also could be seen. Immunohistochemistry staining showed the transplanted NSCs could survive and migrate until 24 weeks and they could differentiate into neurons and oligodendrocytes. The regenerated axons were observed in the scaffold-cell complex with transelectronmicroscopy. The above manifestations were more extensive in group C.
Conclusions: The transplanted NSC can survive and migrate in the spinal cord of rats up to 24 weeks after injury, and they can differentiate into various neural cells. Co-transplantation of cells/PLGA can promote the functional recovery of the injured spinal cord. The effect of co-transplanting NSC + SCs/PLGA is better than transplanting NSC/PLGA alone.
Similar articles
-
Co-transplantation of neural stem cells and Schwann cells within poly (L-lactic-co-glycolic acid) scaffolds facilitates axonal regeneration in hemisected rat spinal cord.Chin Med J (Engl). 2013 Mar;126(5):909-17. Chin Med J (Engl). 2013. PMID: 23489801
-
Failure of Schwann cells as supporting cells for adult neural progenitor cell grafts in the acutely injured spinal cord.Cell Tissue Res. 2007 Jan;327(1):1-13. doi: 10.1007/s00441-006-0252-y. Epub 2006 Aug 29. Cell Tissue Res. 2007. PMID: 16941122
-
Combination of multifaceted strategies to maximize the therapeutic benefits of neural stem cell transplantation for spinal cord repair.Cell Transplant. 2011;20(9):1361-79. doi: 10.3727/096368910X557155. Epub 2011 Mar 7. Cell Transplant. 2011. PMID: 21396156
-
Acute transplantation of olfactory ensheathing cells or Schwann cells promotes recovery after spinal cord injury in the rat.J Neurosci Res. 2004 Mar 1;75(5):632-41. doi: 10.1002/jnr.20029. J Neurosci Res. 2004. PMID: 14991839
-
The role of biodegradable engineered scaffolds seeded with Schwann cells for spinal cord regeneration.Neurochem Int. 2009 Feb;54(2):73-83. doi: 10.1016/j.neuint.2008.11.002. Epub 2008 Nov 25. Neurochem Int. 2009. PMID: 19084565 Review.
Cited by
-
Neuro-immune interactions of neural stem cell transplants: from animal disease models to human trials.Exp Neurol. 2014 Oct;260:19-32. doi: 10.1016/j.expneurol.2013.03.009. Epub 2013 Mar 16. Exp Neurol. 2014. PMID: 23507035 Free PMC article. Review.
-
Neural stem cells grafts decrease neural apoptosis associated with caspase-7 downregulation and BDNF upregulation in rats following spinal cord hemisection.Cell Mol Neurobiol. 2013 Oct;33(7):1013-22. doi: 10.1007/s10571-013-9969-9. Epub 2013 Aug 21. Cell Mol Neurobiol. 2013. PMID: 23963709 Free PMC article.
-
A coaxially extruded heterogeneous core-shell fiber with Schwann cells and neural stem cells.Regen Biomater. 2020 Mar;7(2):131-139. doi: 10.1093/rb/rbz037. Epub 2019 Nov 7. Regen Biomater. 2020. PMID: 32296532 Free PMC article.
-
Emerging stem cell therapies: treatment, safety, and biology.Stem Cells Int. 2012;2012:521343. doi: 10.1155/2012/521343. Epub 2012 Aug 2. Stem Cells Int. 2012. PMID: 22919402 Free PMC article.
-
Laminin-chitosan-PLGA conduit co-transplanted with Schwann and neural stem cells to repair the injured recurrent laryngeal nerve.Exp Ther Med. 2018 Aug;16(2):1250-1258. doi: 10.3892/etm.2018.6343. Epub 2018 Jun 22. Exp Ther Med. 2018. PMID: 30116376 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical